ALDX Aldeyra Therapeutics, Inc.
$1.34▼ -8.22%
Healthcare
Other
After hours
$1.37▲ +2.24%
Sep 11, 7:30 PM ET
Volume 1.56M
Avg Volume (10D) 515.0K
Key Metrics & Fundamentals
Market Cap
$80.84M
P/E Ratio
–
Div Yield
–%
52W Range
1.07 - 5.93
% vs 50 MA
-18.88%
% vs 200 MA
-54.56%
RSI-14
31.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.33
Free Cash Flow
-$4.61M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.38M
COGS
–
Operating Exp
$5.85M
Operating Income
-$5.85M
EBIT
-$5.85M
Pretax Income
-$5.45M
Net Income
-$5.45M
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News

Spyre's Anti-IL-23 Antibody Meets Goal in Ulcerative Colitis Study
Zacks · Sep 9, 2026 1:56 PM

Verastem Stock Skyrockets 121% in 3 Months: Here Is Why
Zacks · Sep 8, 2026 2:09 PM

CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally?
Zacks · Sep 7, 2026 1:28 PM

Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
Zacks · Sep 3, 2026 3:49 PM

FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
Zacks · Sep 3, 2026 3:43 PM

RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals
Zacks · Sep 3, 2026 3:25 PM

Here's Why You Should Add RNTX Stock to Your Portfolio Now
Zacks · Sep 3, 2026 3:01 PM

KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
Zacks · Sep 1, 2026 1:05 PM

Here's Why You Should Add ARQT Stock to Your Portfolio Now
Zacks · Aug 28, 2026 2:58 PM

Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
Zacks · Aug 28, 2026 2:41 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ALDX's money flow as a full page
Social Sentiment
No Reddit posts found for ALDX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.